Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.
Immunization with irradiated sporozoites is currently the most effective vaccination strategy against liver stages of malaria parasites, yet the mechanisms underpinning the success of this approach are unknown. Here we show that the complete development of protective CD8+ T cell responses requires prolonged antigen presentation. Using TCR transgenic cells specific for the malaria circumsporozoite protein, a leading vaccine candidate, we found that sporozoite antigen persists for over 8 weeks after immunization--a remarkable finding since irradiated sporozoites are incapable of replication and do not differentiate beyond early liver stages. Persisting antigen was detected in lymphoid organs and depends on the presence of CD11c+ cells. Prolonged antigen presentation enhanced the magnitude of the CD8+ T cell response in a number of ways. Firstly, reducing the time primed CD8+ T cells were exposed to antigen in vivo severely reduced the final size of the developing memory population. Secondly, fully developed memory cells expanded in previously immunized mice but not when transferred to naïve animals. Finally, persisting antigen was able to prime naïve cells, including recent thymic emigrants, to become functional effector cells capable of eliminating parasites in the liver. Together these data show that the optimal development of protective CD8+ T cell immunity against malaria liver stages is dependent upon the prolonged presentation of sporozoite-derived antigen.
Cockburn
Ian A
IA
Johns Hopkins Malaria Research Institute and Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Baltimore, Maryland, USA.
Chen
Yun-Chi
YC
Overstreet
Michael G
MG
Lees
Jason R
JR
van Rooijen
Nico
N
Farber
Donna L
DL
Zavala
Fidel
F
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology*; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000469:parasitology; D000953:Antigens, Protozoan / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000469:parasitology*; D002454:Cell Differentiation / Q000276:immunology; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology / Q000469:parasitology; D005260:Female; D007114:Immunization; D007156:Immunologic Memory / Q000276:immunology; D008099:Liver / Q000276:immunology* / Q000469:parasitology; D008288:Malaria / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D010967:Plasmodium yoelii / Q000254:growth & development / Q000276:immunology*; D013154:Spleen / Q000276:immunology / Q000469:parasitology; D034101:Sporozoites / Q000254:growth & development / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology / Q000469:parasitology
D000953:Antigens, Protozoan
Science. 2001 Mar 23;291(5512):2413-7
11264538
J Immunol. 2008 Jan 1;180(1):64-71
18097005
J Immunol. 2007 Jun 15;178(12):7563-70
17548591
Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6
2963334
Immunity. 2007 Jun;26(6):827-41
17555991
J Immunol. 2000 Dec 15;165(12):6833-9
11120806
J Immunol Methods. 1996 Jun 14;193(1):93-9
8690935
J Immunol. 2005 Nov 15;175(10):6334-43
16272285
Eur J Immunol. 2006 May;36(5):1179-86
16598821
Infect Immun. 1991 Aug;59(8):2529-34
1855974
Nature. 1967 Oct 14;216(5111):160-2
6057225
Parasite Immunol. 2002 Apr;24(4):221-3
12010486
Immunity. 2008 Oct 17;29(4):650-9
18957267
J Exp Med. 1998 Apr 6;187(7):997-1007
9529316
Blood. 2002 Sep 1;100(5):1734-41
12176895
Immunity. 2002 Aug;17(2):211-20
12196292
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6118-22
7517041
J Exp Med. 2005 Sep 5;202(5):697-706
16147980
Nat Immunol. 2001 May;2(5):381-2
11323687
J Immunol. 2000 Jun 1;164(11):5761-70
10820254
Trop Med Parasitol. 1989 Dec;40(4):468-9
2623430
J Exp Med. 1998 Dec 21;188(12):2205-13
9858507
Am J Trop Med Hyg. 1975 May;24(3):397-401
808142
Am J Pathol. 2007 Jul;171(1):107-15
17591958
Immunity. 2005 May;22(5):561-70
15894274
Immunity. 2006 Jul;25(1):153-62
16860764
Eur J Immunol. 2004 Jun;34(6):1570-7
15162426
Eur J Immunol. 2008 Dec;38(12):3304-15
19009527
Drug Saf. 2004;27(1):25-61
14720085
J Virol. 2000 Sep;74(17):8140-50
10933725
Immunity. 1996 Jun;4(6):565-71
8673703
Int J Parasitol. 2001 Nov;31(13):1499-502
11595237
J Immunol. 2003 Aug 15;171(4):2024-34
12902507
Nature. 2006 Sep 21;443(7109):350-4
16921384
J Virol. 2007 Feb;81(4):2039-46
17151119
Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):113-27
10897348
J Infect Dis. 2009 Mar 15;199(6):899-903
19434915
J Exp Med. 1998 Apr 6;187(7):1009-18
9529317
Int Immunol. 1993 Jun;5(6):647-56
8347558
Clin Exp Immunol. 2005 Sep;141(3):398-404
16045728
Nature. 1989 Sep 28;341(6240):323-6
2477703
J Immunol. 2004 Feb 15;172(4):2487-95
14764721
J Exp Med. 1998 Dec 7;188(11):2163-73
9841929
J Immunol. 1993 Jul 15;151(2):890-9
7687623
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11819-24
12185251
J Immunol. 2003 Dec 15;171(12):6466-77
14662846
Viral Immunol. 2003;16(1):3-16
12725684
Nat Immunol. 2001 May;2(5):423-9
11323696
J Exp Med. 2001 Jul 16;194(2):173-80
11457892
Nat Immunol. 2007 Feb;8(2):181-90
17195844
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4066-8
7732032
J Exp Med. 2006 Oct 2;203(10):2263-9
16966427
Nature. 1987 Dec 17-23;330(6149):664-6
3120015
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8670-5
15163797
Immunity. 2006 Apr;24(4):439-49
16618602
Immunity. 2008 Jun;28(6):859-69
18499487
Immunity. 1997 Jul;7(1):97-112
9252123
Nat Med. 2007 Sep;13(9):1035-41
17704784
Nat Immunol. 2001 May;2(5):415-22
11323695